Governance Evotec SE

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 16:35:09 13/07/2026 BST			5-day change	1st Jan Change
4.942 ^EUR	-0.08%		-3.85%	-9.32%

07-13	Evotec withdraws profit outlook, revenue comes in below expectations	DP
06-30	Evotec Expands Prefabricated Drug Manufacturing Offerings	MT

Executive Committee: Evotec SE

Manager

Positions heldSince

Christian Wojczewski

55 year

Chief Executive Officer

30/06/2024

Cord Dohrmann

62 year

Chief Tech/Sci/R&D Officer

31/08/2010

Aurélie Dalbiez

49 year

Human Resources Officer

14/06/2024

Sarah Fakih

Investor Relations Contact	31/12/2025
Public Communications Contact	31/12/2025

Ingrid Müller

Chief Operating Officer

30/04/2026

Claire Hinshelwood

Director of Finance/CFO

30/04/2026

Composition of the Board of Directors: Evotec SE

Director

CommitteesSince

Dieter Weinand

65 year

Audit Committee	17/08/2023
Governance Committee Chair
Nominating Committee Chair

Constanze Ulmer-Eilfort

64 year

Audit Committee	31/05/2021
Compensation Committee	20/06/2023
Governance Committee	20/06/2023
Nominating Committee	20/06/2023

Camilla Macapili Languille

43 year

Audit Committee	21/06/2022
Compensation Committee	31/08/2024
HR Committee	31/08/2024

Roland Sackers

58 year

Compensation Committee	18/06/2019
Nominating Committee	18/06/2019
Audit Committee Chair	18/06/2019

Wolfgang Hofmann

Director/Board Member

10/06/2026

Wesley Wheeler

70 year

Director/Board Member	09/06/2024
Independent Dir/Board Member	09/06/2024

Duncan McHale

59 year

Director/Board Member

09/06/2024

Latest Appointments: Evotec SE

06-11	Evotec Se Announces Board Changes	CI
06-02	Evotec SE Appoints Rui Wang as Executive Vice President, Head of Global In Silico and AI	CI
04-15	Evotec SE Appoints Ingrid Mller as Chief Operating Officer, Effective May 1, 2026	CI
04-07	Evotec Se Announces Term Completion of Prof. Dr. Iris Löw-Friedrich as Chairwoman of the Supervisory Board on June 11, 2026	CI
04-06	MAK Capital Sends Letter to Evotec?s Supervisory & Management Board	CI
04-01	Evotec SE Appoints Ashiq H. Khan as EVP Global Head, Chief Commercial Officer	CI
01-02	Evotec SE Announces Executive Changes	CI

More news

Former Officers and Directors: Evotec SE

Insider

Positions held

SinceUntil

Iris Löw-Friedrich

Director/Board Member	16/06/2014	14/06/2021
Chairman	14/06/2021	10/06/2026
Independent Dir/Board Member	16/06/2014	10/06/2026

Paul Robert Hitchin

Director of Finance/CFO

28/02/2025

29/04/2026

Volker Braun

Investor Relations Contact

31/12/2025

Laetitia Rouxel

Director of Finance/CFO	31/03/2023	27/02/2025
Corporate Officer/Principal	06/02/2023	31/03/2023

Hinnerk Rohwedder

Public Communications Contact

31/12/2020

31/12/2024

Craig Johnstone

Chief Operating Officer	31/12/2018	30/12/2024
Corporate Officer/Principal	30/04/2012	-

Matthias Evers

Corporate Officer/Principal

30/04/2022

30/09/2024

Elaine Sullivan

Director/Board Member

08/06/2015

09/06/2024

Bernd Mühlenweg

Corporate Officer/Principal

31/10/2022

31/05/2024

Werner Lanthaler

Chief Executive Officer	05/03/2009	02/01/2024
Investor Relations Contact	05/03/2009	-
Public Communications Contact	05/03/2009	-

Karen Lackey

Private Equity Analyst

31/05/2019

31/05/2023

Enno Spillner

Director of Finance/CFO

17/07/2016

28/02/2023

Kasim Kutay

Director/Board Member

21/06/2022

Wolfgang Plischke

Chairman	16/06/2014	14/06/2021
Independent Dir/Board Member	16/06/2014	14/06/2021

Mario Polywka

Chief Operating Officer	29/02/2004	30/12/2018
Director/Board Member	18/06/2019	09/06/2024
Chief Executive Officer	02/01/2024	30/06/2024

Leesa Gentry

Corporate Officer/Principal

31/10/2005

30/11/2018

Paul Herrling

Director/Board Member	16/06/2014	13/06/2017
Independent Dir/Board Member	16/06/2014	13/06/2017

Michael Shalmi

Director/Board Member

13/06/2017

Colin Michael Bond

Director of Finance/CFO

12/08/2010

29/06/2016

Monika Conradt

Human Resources Officer

31/05/2016

Walter Wenninger

Director/Board Member	16/06/2014	08/06/2015
Chairman	26/06/2013	16/06/2014

Andreas Pinkwart

Director/Board Member

15/06/2011

16/06/2014

Roland Oetker

Director/Board Member

15/06/2011

16/06/2014

Mary C. Tanner

Director/Board Member

03/05/2010

16/06/2014

Bernd Hirsch

Director/Board Member	15/12/2013	-
Independent Dir/Board Member	15/12/2013	-

Claus Tycho Bræstrup

Director/Board Member	11/06/2013	-
Independent Dir/Board Member	11/06/2013	-

Peter John Fellner

Director/Board Member

16/08/2009

15/06/2011

Corey Goodman

Director/Board Member

31/12/2009

Cony D’Cruz

Corporate Officer/Principal

31/12/2000

31/12/2009

Jeffrey Farrow

Director of Finance/CFO

30/04/2008

31/12/2009

Jan Thyen

Corporate Officer/Principal

31/01/2006

31/12/2009

Charmion Gillmore

Human Resources Officer	-	30/05/2009
Public Communications Contact	-	30/05/2009

Tim Tasker

Chief Tech/Sci/R&D Officer

29/04/2009

Jörn Aldag

Chief Executive Officer	31/10/1997	30/12/2008
President	31/10/1997	30/12/2008

Flemming Ørnskov

Director/Board Member	14/09/2009	03/05/2010
Chairman	03/05/2010	-

Heinz Riesenhuber

Chairman

31/07/2008

William John Jenkins

Director/Board Member

31/12/2007

Peer Schatz

Director/Board Member

31/12/2007

Klaus Maleck

Director of Finance/CFO	31/03/2007	12/08/2010
Corporate Officer/Principal	12/08/2010	-

Dirk H. Ehlers

Director/Board Member	31/12/2000	31/12/2006
Director of Finance/CFO	31/12/2000	31/12/2006

Hubert Birner

Director/Board Member

31/05/2005

Timm H. Jessen

Chief Operating Officer	31/10/1997	31/05/2004
Chief Tech/Sci/R&D Officer	31/10/1997	31/05/2004

Rodney Weldon Turner

Corporate Officer/Principal

31/12/1994

31/12/2000

Manfred Eigen

Director/Board Member	07/06/1998	07/06/1998
Founder	07/12/1993	07/06/1998

Ulrich Aldag

Founder	07/12/1993	27/02/1998
Corporate Officer/Principal	27/02/1998	27/02/1998

Mark Richard Ashton

Corporate Officer/Principal

31/12/1994

Heinrich Maria Schulte

Founder

07/12/1993

Karsten Henco

Founder	07/12/1993	-
President	07/12/1993	-

Freimut Leidenberger

Director/Board Member	07/12/1993	-
Founder	07/12/1993	-

Rudolf Rigler

Founder

07/12/1993

Charles Weissmann

Founder

07/12/1993

Mark Winderlich

Corporate Officer/Principal

Andrew Cross

Sales & Marketing

Dirk Plaga

Corporate Officer/Principal

Erich Greiner

Corporate Officer/Principal

Jürgen Kupper

Corporate Officer/Principal

Baker Mckenzie

Director/Board Member

Edwin Moses

Director/Board Member

John Walker

Director/Board Member

Sean Marett

Corporate Officer/Principal

Dirk Ullmann

Corporate Officer/Principal

Kam Dhaliwal

Corporate Officer/Principal

Gordon J. Woodrow

Corporate Officer/Principal

Mohammad Yaqoob

Corporate Officer/Principal

Ian M. Hunneyball

Chief Tech/Sci/R&D Officer

Thomas Hanke

Director/Board Member

John A. Kemp

Chief Tech/Sci/R&D Officer

David Brister

Corporate Officer/Principal

Gabriele Hansen

Public Communications Contact	-	-
Sales & Marketing	-	-

Doris Kynast

Investor Relations Contact	-	-
Public Communications Contact	03/05/2010	-

Jesper Paul Fredrik Wiklund

Corporate Officer/Principal

Adrian Howd

Corporate Officer/Principal

Peter Seufer-Wasserthal

Corporate Officer/Principal

Phillip James Boyd

Director of Finance/CFO

Robert Phelps

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	11
Female	3

Of which Executive Committee

Male	4
Female	2

Of which Directors

Male	6
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, womenâ€™s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Employees

4,526

Sector

Biotechnology & Medical Research

Calendar

Earnings release - Q2 2026

More about the company